Clinical Trial Update: An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201) [Phase 3]

View source ↗

Summary

Phase 3 efficacy and safety results of desloratadine (MK-4117) in Japanese participants with chronic urticaria have been reported. The trial was sponsored by Or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urticaria

Drugs mentioned

• Desloratadine (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Urticaria | Phase 3 | Status: COMPLETED | Results posted: 2014-10-30